Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.7.11.13 (protein kinase C)
 49,245 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Arachidonic acid is released by phospholipase A2 when activation of N-methyl-D-aspartate (NMDA) receptors by neurotransmitter glutamate raises the calcium concentration in neurons, for example during the initiation of long-term potentiation and during brain anoxia. Here we investigate the effect of arachidonic acid on glutamate-gated ion channels by whole-cell clamping isolated cerebellar granule cells. Arachidonic acid potentiates, and makes more transient, the current through NMDA receptor channels, and slightly reduces the current through non-NMDA receptor channels. Potentiation of the NMDA receptor current results from an increase in channel open probability, with no change in open channel current. We observe potentiation even with saturating levels of agonist at the glutamate- and glycine-binding sites on these channels; it does not result from conversion of arachidonic acid to lipoxygenase or cyclooxygenase derivatives, or from activation of protein kinase C. Arachidonic acid may act by binding to a site on the NMDA receptor, or by modifying the receptor's lipid environment. Our results suggest that arachidonic acid released by activation of NMDA (or other) receptors will potentiate NMDA receptor currents, and thus amplify increases in intracellular calcium concentration caused by glutamate. This may explain why inhibition of phospholipase A2 blocks the induction of long-term potentiation.
 ...
PMID:Potentiation of NMDA receptor currents by arachidonic acid. 137 30

1. We examined the role of adenosine in the development of anoxic injury in a CNS white matter tract, the rat optic nerve. Application of adenosine protected the rat optic nerve from anoxic injury; 2.5 microM adenosine increased compound action potential (CAP) recovery after a standard 60-min anoxic period from 28.6 +/- 2.5%, mean +/- SE, to 51.0 +/- 3.1% (P < 0001). The protective effect of adenosine was abolished by the adenosine receptor antagonist theophylline (100 microM). 2. The protective effect of adenosine evolved slowly after adenosine application; maximum protection required 60 min of adenosine exposure before the onset of anoxia. The concentration dependence of the protective effect was parabolic, with maximum protection at 2.5 microM. Neither high nor very low adenosine concentrations protected against anoxia. These characteristics are similar to those previously found for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the same preparation. 3. Inhibition of adenosine receptors (100 microM theophylline) reduced the level of recovery from that found under control conditions (24.3 +/- 4.8% compared with 36.2 +/- 2.5%, P < 0.05). The adenosine uptake inhibitor propentofylline, which potentiates release of endogenous adenosine during brain anoxia, significantly increased CAP recovery after anoxia. This effect was abolished by theophylline. It appeared therefore that release of endogenous adenosine limited injury in the optic nerve during anoxia. 4. The protective effect of adenosine was removed by pretreatment with the protein kinase C (PKC) inhibitor staurosporine (10 nM), indicating that activation of PKC was required for protection after exposure to adenosine.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. 789 78